نتایج جستجو برای: stereotactic radiotherapy

تعداد نتایج: 69462  

Journal: :Current opinion in oncology 1995
P Y Wen J S Loeffler

The diagnosis of pituitary tumors has improved with advances in magnetic resonance and radionuclide and hormonal testing. The widespread availability of neuroimaging has significantly increased the number of incidental pituitary tumors coming to medical attention. Conventional therapy with transsphenoidal surgery, external-beam radiotherapy, and bromocriptine has enabled the majority of patient...

Journal: :Rehabilitation nursing : the official journal of the Association of Rehabilitation Nurses 1948
Robert G Keim

A patient with progressive visual loss was found to have an optic nerve sheath meningioma. The patient was treated with stereotactic radiotherapy, a computer-guided stereotactic technique that minimizes the risk of radiation-induced optic neuropathy. Six months after treatment, the patient was doing well and showed no signs of radiation-induced optic neuropathy.

2012
Arjun Sahgal

A section of this issue of TCRT focuses on four articles dealing with technological advances in brain and spine radiosurgery. With the evolution of radiation technology to allow for high precision image-guided radiotherapy as an integrated part of mainstream linear accelerators, the practice of stereotactic radiosurgery (SRS) is commonly applied to the brain and is rapidly developing as an attr...

2015
Alexander Muacevic John R Adler Anand Mahadevan Nergiz Dagoglu Jennifer F Tseng Khalid Khawaja Amy Evenson

Surgical treatment remains the only curative treatment for gallbladder cancer. However, even after liver resection, locoregional failure seems to be a significant problem. While there is no Level I evidence, multiple studies have shown benefit for adjuvant radiation in high-risk patients. After extensive liver resection, tolerance to conventional chemoradiation may be limited by potential liver...

2017
Marianne Aznar Alejandra Méndez Romero Ben J M Heijmen

Stereotactic body radiotherapy is a highly technology-driven treatment modality. The wider availability of in-room imaging and advanced radiotherapy delivery techniques has led to more institutions offering stereotactic ablative therapy (SABR). While some technological challenges remain, the crucial point for the next generation of SABR clinical trials is that today's technology is used correct...

2017
C Boudou M C Biston J F Adam H Elleaume

In synchrotron stereotactic radiotherapy (SSR) the tumor is loaded with a high Z element, and exposed to monochromatic x-rays from a synchrotron source, in stereotactic conditions. The SSR treatment efficiency is related to the heavy element concentration achievable in the tumor, to the radiation energy, and the irradiation geometry [1,2]. The experimental dose verification of SSR in three dime...

Journal: :Radiation Oncology (London, England) 2008
Peter Lindvall Per Bergström Per-Olov Löfroth Roger Henriksson A Tommy Bergenheim

BACKGROUND Hypofractionated radiotherapy has been used for the treatment of AVMs and brain metastases. Hypofractionation necessitates the use of a relocatable stereotactic frame that has to be applied on several occasions. The stereotactic frame needs to have a high degree of reproducibility, and patient positioning is crucial to achieve a high accuracy of the treatment. METHODS In this study...

2016
Yuanli Dong Chengrui Fu Hui Guan Tianyi Zhang Zicheng Zhang Tao Zhou Baosheng Li

Despite advances in the fields of surgery, chemotherapy and radiotherapy, the prognosis for high-grade glioma (HGG) remains unsatisfactory. The majority of HGG patients experience disease recurrence. To date, no standard treatments have been established for recurrent HGG. Repeat surgery and chemotherapy demonstrate moderate efficacy. As recurrent lesions are usually located within the previousl...

Journal: :Expert review of anticancer therapy 2013
Betul Berber Juan R Sanabria Kelly Braun Min Yao Rodney J Ellis Charles A Kunos Jason Sohn Mitchell Machtay Bin S Teh Zhibin Huang Nina A Mayr Simon S Lo

The management of pancreatic cancer continues to be challenging. Despite surgical, genetic and molecular advances, its overall prognosis remains poor. Surgical resection is the only modality that offers a chance for a cure, with an overall survival rate of 10-20% at 5 years. However, only 20% of the patients are surgical candidates because of locally advanced disease or systemic stage at presen...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید